How many institutions held ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in Q1 2016?

34 institutional investors reported ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value for Q1 2016. Use the holders table for investor-level position and value details.

Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

Q: What does CUSIP 00461U105 represent in this 13F holders report?

CUSIP 00461U105 is the security identifier for ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value used to aggregate holder disclosures.

CUSIP: 00461U105

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Common Stock, $0.00001 par value
Shares outstanding: 140,909,091
Total 13F shares: 14,605,233
Share change: +125,336
Total reported value: $276,749,000
Price per share: $18.95
Number of holders: 34
Value change: +$2,035,314
Number of buys: 20
Number of sells: 11

Quarterly Holders Quick Answers

What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2016
Previous quarter: Q4 2015

Recent filing periods for CUSIP 00461U105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	2.7%	3,804,279	$102,487,000	—	31 Dec 2015	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.8%	2,564,553	$69,089,000	—	31 Dec 2015	13F
FRANKLIN RESOURCES INC	13F	Company	1.2%	1,654,894	$44,583,000	—	31 Dec 2015	13F
Rock Springs Capital Management LP	13F	Company	0.64%	896,154	$24,142,000	—	31 Dec 2015	13F
Cormorant Asset Management, LP	13F	Company	0.46%	647,944	$17,456,000	—	31 Dec 2015	13F
BlackRock Fund Advisors	13F	Company	0.11%	155,186	$4,181,000	—	31 Dec 2015	13F
VANGUARD GROUP INC	13F	Company	0.11%	149,988	$4,040,000	—	31 Dec 2015	13F
TURNER INVESTMENTS LLC	13F	Company	0.04%	57,694	$1,554,000	—	31 Dec 2015	13F
NORTHERN TRUST CORP	13F	Company	0.04%	57,142	$1,539,000	—	31 Dec 2015	13F
NORGES BANK	13F	Company	0.04%	50,000	$1,347,000	—	31 Dec 2015	13F
STATE STREET CORP	13F	Company	0.03%	44,653	$1,202,000	—	31 Dec 2015	13F
Spark Investment Management LLC	13F	Company	0.03%	38,616	$1,040,000	—	31 Dec 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	36,567	$985,000	—	31 Dec 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.02%	22,751	$613,000	—	31 Dec 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.01%	19,973	$538,000	—	31 Dec 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.01%	16,557	$447,000	—	31 Dec 2015	13F
Bank of New York Mellon Corp	13F	Company	0.01%	14,283	$385,000	—	31 Dec 2015	13F
E. E. Geduld	13F	Individual	0.01%	13,000	$350,000	—	31 Dec 2015	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.01%	12,953	$349,000	—	31 Dec 2015	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	10,650	$287,000	—	31 Dec 2015	13F
TEACHERS ADVISORS, LLC	13F	Company	0%	5,687	$153,000	—	31 Dec 2015	13F
Nationwide Fund Advisors	13F	Company	0%	3,418	$92,000	—	31 Dec 2015	13F
BLACKROCK ADVISORS LLC	13F	Company	0%	1,937	$52,000	—	31 Dec 2015	13F
STRS OHIO	13F	Company	0%	1,900	$51,000	—	31 Dec 2015	13F
CITIGROUP INC	13F	Company	0%	1,734	$47,000	—	31 Dec 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	1,660	$45,000	—	31 Dec 2015	13F
DEUTSCHE BANK AG\	13F	Company	0%	1,446	$38,000	—	31 Dec 2015	13F
BARCLAYS PLC	13F	Company	0%	1,000	$26,000	—	31 Dec 2015	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	812	$22,000	—	31 Dec 2015	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	519	$13,982	—	31 Dec 2015	13F
MORGAN STANLEY	13F	Company	0%	391	$11,000	—	31 Dec 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	139	$4,000	—	31 Dec 2015	13F
UBS Group AG	13F	Company	0%	109	$3,000	—	31 Dec 2015	13F

Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) as of Q1 2016

As of 31 Mar 2016, Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,605,233 shares. The largest 10 holders included Vivo Capital, LLC, FMR LLC, RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, Rock Springs Capital Management LP, Cormorant Asset Management, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, TURNER INVESTMENTS, L.P., and STATE STREET CORP. This page lists 34 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders

Q1 2016 holders

Holder diff

Investor	Q4 2015 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q4 2015 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.